Status:
COMPLETED
The Influence of Extracorporeal Photopheresis on Skin Sclerosis
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Scleroderma, Systemic
Graft Vs Host Disease
Eligibility:
All Genders
18+ years
Brief Summary
Extracorporeal photopheresis (ECP), also known as extracorporeal photoimmunotherapy or photochemotherapy, is a leukapheresis-based therapy that has been in clinical use for over three decades after re...
Detailed Description
Background and Rationale: Extracorporeal photopheresis: In this immunomodulatory therapy, the apheresis leukocytes of the patients are irradiated with ultraviolet (UV) A in the presence of a photose...
Eligibility Criteria
Inclusion
- Systemic sclerosis, morphea, sclerodermiform GvHD or eosinophilic fasciitis, with duration less than 5 years.
- Ability and willingness to both understand and carry out the study requirements
Exclusion
- 1\. Participation in another study, currently or in the previous four weeks.
Key Trial Info
Start Date :
February 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 6 2021
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04752397
Start Date
February 12 2021
End Date
September 6 2021
Last Update
November 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité-Universitätsmedizin Berlin
Berlin, Germany, 10117